Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ: AUPH · Real-Time Price · USD
16.04
-0.33 (-2.02%)
At close: Apr 28, 2026, 4:00 PM EDT
16.10
+0.06 (0.35%)
After-hours: Apr 28, 2026, 4:40 PM EDT
Aurinia Pharmaceuticals Employees
Aurinia Pharmaceuticals had 128 employees as of December 31, 2025. The number of employees decreased by 2 or -1.54% compared to the previous year.
Employees
128
Change (1Y)
-2
Growth (1Y)
-1.54%
Revenue / Employee
$2,211,367
Profits / Employee
$2,243,766
Market Cap
2.08B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Sarepta Therapeutics | 835 |
| Ascentage Pharma Group International | 767 |
| Adaptive Biotechnologies | 624 |
| Ocular Therapeutix | 325 |
| Zymeworks | 264 |
| Capricor Therapeutics | 231 |
| Stoke Therapeutics | 170 |
| Definium Therapeutics | 106 |
AUPH News
- 4 weeks ago - Aurinia Pharmaceuticals to Acquire Kezar Life Sciences for $6.955 in Cash per Share Plus a Contingent Value Right - Business Wire
- 5 weeks ago - MKT Capital Applauds Aurinia Pharmaceuticals' Management Transition - Business Wire
- 5 weeks ago - Why Aurinia Pharmaceuticals Stock Is Surging Monday Morning - Benzinga
- 5 weeks ago - Aurinia Announces Management Transition - Business Wire
- 2 months ago - Aurinia Pharmaceuticals (AUPH) Stock Drops After Strong Quarter, Softer Forward Revenue Targets - Benzinga
- 2 months ago - Aurinia Pharmaceuticals Earnings Call Transcript: Q4 2025 - Transcripts
- 2 months ago - Aurinia Pharmaceuticals Reports Financial Results for the Three and Twelve Months Ended December 31, 2025 and Provides Update on Recent Business Progress - Business Wire
- 2 months ago - Aurinia Pharmaceuticals to Report Financial Results for the Three and Twelve Months Ended December 31, 2025 and Provide Update on Recent Business Progress on February 26, 2026 - Business Wire